GlaxoSmithKline Pharma surges on reporting 14% rise in Q2 net profit

11 Aug 2011 Evaluate

GlaxoSmithKline Pharma is currently trading at Rs. 2142.00, up by 19.80 points or 0.93% from its previous closing of Rs. 2122.20 on the BSE.

The scrip opened at Rs. 2122.00 and has touched a high and low of Rs. 2134.80 and Rs. 2120.15 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2475.00 on 14-Jun-2011 and a 52 week low of Rs. 1850.00 on 31-Aug-2010.

Last one week high and low of the scrip stood at Rs. 2257.05 and Rs. 2092.25 respectively. The current market cap of the company is Rs. 17975.67 crore.

The promoters holding in the company stood at 50.67% while Institutions and Non-Institutions held 32.66% and 16.67% respectively. 

GlaxoSmithKline Pharmaceuticals has reported unaudited results for the second quarter ended June 30, 2011.

The company’s net profit for the quarter ended June 30, 2011 rose by 14.38% at Rs 147.54 crore as compared to Rs 128.99 crore for the corresponding quarter last year. Its total income increased 13.07% at Rs 573.85 crore for the quarter under review from Rs 507.51 crore for the same quarter last year.

GlaxoSmithKline Pharmaceuticals, is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others.

Glaxosmithkline Phar Share Price

2562.20 52.90 (2.11%)
05-Dec-2025 14:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.45
Dr. Reddys Lab 1275.00
Cipla 1524.95
Zydus Lifesciences 933.45
Lupin 2104.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×